Emcure Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: EMCURE | BSE: 544210
₹999.90 8.30 (0.84 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 980.10
High (₹) 1,009.25
Low (₹) 980.10
Prev. Close (₹) 991.60
Volume 4,746
VWAP (₹) 996.05
ROCE (%) 21.20
Industry P/E 43.99
TTM P/E 31.18
P/B Ratio 5.78
Market Cap (₹) Cr.18,862.68
Dividend Yield (%)0.30
EPS (₹) 27.54
ROE15.98%
Sales Growth (%) 11.23
Profit Growth (%)-6.1
Day Range
1,009.251,009.25
52 Week Range
942.451,577.50
Historical Returns
Returns (6M)
-29.46 %
Returns (1Y)
-26.42 %
Returns (3Y)
-26.42 %
Returns (5Y)
-26.42 %
Returns (6M)
-29.46 %
Returns (1Y)
-26.42 %
Returns (3Y)
-26.42 %
Returns (5Y)
-26.42 %
SWOT Analysis
Technicals
Technical Rating
RSI 31.25
MFI 51.35
ATR 66.51
Commodity Channel Index -95.77
ROC125 -28.04
ROC21 -22.44
Williams %R -85.86
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 1,010.64 | 1,024.52 | 1,039.79 | 995.37 | 981.49 | 966.22 | 952.34 |
Week Ago | 1,065.40 | 1,136.30 | 1,188.45 | 1,013.25 | 942.35 | 890.20 | 819.30 |
Month Ago | 1,377.74 | 1,402.12 | 1,416.59 | 1,363.27 | 1,338.89 | 1,324.42 | 1,300.04 |
EMA & SMA
999.90
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
16
5 Day 977.38
9 Day 1035.10
10 Day 1058.97
12 Day 1107.05
14 Day 1116.63
20 Day 1136.78
26 Day 1193.24
50 Day 1289.32
100 Day 1348.70
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
11 Feb, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about Transcript |
11 Feb, 2025 | BSE India | The transcript of the Earnings Call for the Q3 FY25, held on February 06, 2025 at 5:30 p.m. (IST) |
07 Feb, 2025 | BSE India | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received by Company''s subsidiary on February 06, 2025. |
07 Feb, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed |
07 Feb, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |
06 Feb, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about Link of Recording |
06 Feb, 2025 | BSE India | Audio recording of the call held today i.e. on February 06, 2025, is available on our website. |
06 Feb, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding ''Disclosure under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015''. |
06 Feb, 2025 | NSE India | Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024 |
06 Feb, 2025 | BSE India | Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 25 Jan, 2025 | 06 Feb, 2025 |
Quarterly Results | -- | 29 Oct, 2024 | 07 Nov, 2024 |
Quarterly Results | -- | 07 Aug, 2024 | 13 Aug, 2024 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jul, 2024 |
---|
About Emcure Pharmaceuticals
Emcure Pharmaceuticals is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3497.66 Cr. and Equity Capital is Rs. 181.15 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1981
Managing Director
Mr. Satish Ramanlal Mehta
NSE Symbol
EMCURE
Emcure Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Berjis Minoo Desai | Chairman & Non-Exe.Director |
Mr. Satish Ramanlal Mehta | Managing Director & CEO |
Mr. Sunil Rajanikant Mehta | Whole Time Director |
Ms. Namita Vikas Thapar | Whole Time Director |
Mr. Samit Satish Mehta | Whole Time Director |
Mr. Mukund Keshao Gurjar | Whole Time Director |
Mr. Samonnoi Banerjee | Non Exe. & Nominee Director |
Mr. Palamadai Sundararajan Jayakumar | Independent Director |
Mr. Vijay Keshav Gokhale | Independent Director |
Ms. Vidya Rajiv Yeravdekar | Independent Director |
Mr. Shailesh Kripalu Ayyangar | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,643.75 ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Emcure Pharmaceuticals
What is the share price of Emcure Pharmaceuticals?
The share price of Emcure Pharmaceuticals on 21 Feb, 2025 is ₹ 999.90.
What is 52W high and 52W low share price of Emcure Pharmaceuticals?
The highest and lowest 52W share prices of Emcure Pharmaceuticals are ₹ 1577.500 and ₹ 1226.500
What is the market cap of Emcure Pharmaceuticals?
The market capitalization of Emcure Pharmaceuticals as of 21 Feb, 2025 is ₹ 18,862.68 Crores
What is the P/E ratio of Emcure Pharmaceuticals?
The current P/E ratio of Emcure Pharmaceuticals as of 21 Feb, 2025 is 43.99
What is the PB ratio of Emcure Pharmaceuticals?
The PB ratio of Emcure Pharmaceuticals as of 21 Feb, 2025 is 5.78
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)